{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7546,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5",
      "docSlug": "9fdf48e9810bc95033985664c53d0e5a",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide uses a grid layout to present 10 advisors, each with a headshot, name, role, and company logo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/20",
      "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5",
      "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 19,
          "beatId": "094ed220-c5e2-4649-947d-ee0f4fc460b9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "Slides 19 and 20 present the leadership team and industry advisors",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5",
      "docSlug": "9fdf48e9810bc95033985664c53d0e5a",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a DNA helix as a creative timeline background, reflecting the company's focus on molecular diagnostics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/21",
      "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5",
      "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5",
      "docSlug": "9fdf48e9810bc95033985664c53d0e5a",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes income statement metrics, balance sheet data, and equity structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/22",
      "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5",
      "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5",
      "docSlug": "9fdf48e9810bc95033985664c53d0e5a",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/23",
      "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5",
      "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5",
      "docSlug": "9fdf48e9810bc95033985664c53d0e5a",
      "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
      "authorId": "mainz-biomed-nv",
      "authorName": "Mainz Biomed",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/24",
      "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5",
      "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/2p7UWbazKfrxoGoTDmfFZmCCYfm5OF0QEHlDN-BT8jQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/1",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/0gjAf-Js4rjYwSxV2OT9HXlpu-4kSVrpo8t4PM-wMGI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/Om9Byg8-2okK-mMbsKirHvWpFADZHJ41h8pGbdDaNQs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/dK4vbJ3D0z4CX8F5pdSxjEhmfytxRS1e0-Eh4hZ1Jko/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMDgwZGYwOGQ3YTc1ZDk1ZjUyM2Q0ZGYyNmYwMzdhZS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/2",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "thesis_headline",
      "function": "present_solution",
      "notes": "The slide uses a two-column layout to contrast a specific lead asset (MAT2203) with broader pipeline opportunities.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/3",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a combination of molecular diagrams and bulleted benefits to explain the LNC technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/4",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a two-part framework: Targeting (left) and Delivery (right).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/5",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/6",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "Uses authority-citation framework to build urgency by aggregating external validation from reputable news and scientific sources.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/7",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-7",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a before-after-bridge style logic to frame the solution.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/8",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-8",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a process flow diagram to map clinical outcomes to specific trial metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/9",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-9",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "This is a citation slide showcasing scientific validation of the company's technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/10",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-10",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a human silhouette as a central diagram to map specific fungal pathogens and resulting conditions to anatomical locations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/11",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-11",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Focuses on clinical success in a compassionate use setting.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/12",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-12",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "other",
      "function": "illustrate_case",
      "notes": "The slide uses a timeline-based case study format to demonstrate clinical efficacy and safety.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/13",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-13",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide highlights both the clinical urgency (toxicity, resistance) and the commercial potential (orphan disease status).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/14",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-14",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "280995d8-784d-4cf6-887d-11df1485e9b8",
          "evidence": "The document emphasizes the growing threat of IFIs",
          "position": 0,
          "objective": "Highlight the consequences of not addressing IFIs",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "7aa25a8a-9932-4625-b5d8-1d7641445816",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the growing threat of IFIs and high unmet medical need in IA",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 14,
          "from": 14,
          "beatId": "4c746dd8-1e95-4d84-97e7-5921f00a9ef1",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document highlights the limitations of current treatments",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Focuses on clinical trial strategy and regulatory milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/15",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-15",
      "loopMatches": [
        {
          "to": 17,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "00b1ada5-9ed0-47ca-b8a0-eb84773cc71e",
          "evidence": "The document outlines the value proposition of MAT2203",
          "position": 1,
          "objective": "Present MAT2203 as a solution with high potential",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines the randomization, treatment arms, timeline, patient population criteria, and primary/secondary endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/16",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-16",
      "loopMatches": [
        {
          "to": 17,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "00b1ada5-9ed0-47ca-b8a0-eb84773cc71e",
          "evidence": "The document outlines the value proposition of MAT2203",
          "position": 1,
          "objective": "Present MAT2203 as a solution with high potential",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a combination of an additive equation for the value prop and a chevron-based timeline for the life cycle management.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/17",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-17",
      "loopMatches": [
        {
          "to": 17,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "00b1ada5-9ed0-47ca-b8a0-eb84773cc71e",
          "evidence": "The document outlines the value proposition of MAT2203",
          "position": 1,
          "objective": "Present MAT2203 as a solution with high potential",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 8,
          "beatId": "eafaf135-71d7-4ccf-a416-5600c022e3da",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents MAT2203 as a solution and provides supporting evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/18",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/19",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Uses a chevron-based process flow to represent maturity stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/20",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart shows dose-response curves where LNC formulations consistently outperform Taxol.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/21",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a timeline diagram to explain the experimental design and a line chart to show tumor volume reduction over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/22",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The study is an ex-vivo human whole blood study using 80 ug/mL LNC and 512 ng/mL Cy5-labeled siRNA cargo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/23",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide compares LNC formulations against IMQ-only and IL-17A antibody controls.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/24",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b279-75da-94b2-8ad8944b7652",
      "docSlug": "3080df08d7a75d95f523d4df26f037ae",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes study design details (n=55, female C57BL/6 mice) and statistical significance markers for treatment groups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b279-75da-94b2-8ad8944b7652/25",
      "deckHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652",
      "deckAnchorHref": "/decks/019de076-b279-75da-94b2-8ad8944b7652#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}